BriaCell TherapeuticsBCTX 
$0.70-11.39%24h
-11.39%24h
Global rank32428
Market cap$10.93M
Change 7d-14.63%
YTD Performance-88.14%
SP500 benchmarkUnderperform
P/E-0.54
P/S0
Revenue$0
Earnings-$20.30M
Dividend yield-
BriaCell Therapeutics (BCTX) Cash on Hand
BCTX Cash on Hand in 2022: $28.42M
According to BriaCell Therapeutics latest financial reports the cash on hand of BCTX is $28.42M, an decrease of -48.22% to 2022. At the end of 2022 company had $54.89M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
BCTX Cash on Hand History from 2019 to 2023
-
Value:-
BCTX Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $28.42M | -48.22% |
| 2022 | $54.89M | -28.33% |
| 2021 | $76.59M | 360332.37% |
| 2020 | $21.25K | -85.52% |
| 2019 | $146.71K | - |
View the Top Cash on Hand Companies 
